![Benoit Bouche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benoit Bouche
Chief Executive Officer at
Pacific Biomarkers, Inc.
Profile
Benoit Bouche is currently the Chief Executive Officer at Pacific Biomarkers, Inc., the President, Chief Executive Officer & Director at Nexelis Laboratories Canada, Inc., and the Operating Partner at Ampersand Management LLC.
He previously served as the President & Chief Executive Officer at NEOMED-LABS, Inc. and as an Analyst at Puilaetco in 2001.
Benoit Bouche active positions
| Companies | Position | Start |
|---|---|---|
Pacific Biomarkers, Inc.
 Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Provides biomarker testing services | Chief Executive Officer | - |
Nexelis Laboratories Canada, Inc.
 Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Chief Executive Officer | 2016-12-31 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Private Equity Investor | 2022-03-31 |
Former positions of Benoit Bouche
| Companies | Position | End |
|---|---|---|
Puilaetco
 Puilaetco Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2001-12-04 |
NEOMED-LABS, Inc.
 NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Puilaetco
Puilaetco Investment Banks/BrokersFinance Provides brokerage services | Finance |
NEOMED-LABS, Inc.
NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pacific Biomarkers, Inc.
Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Provides biomarker testing services | Health Technology |
Nexelis Laboratories Canada, Inc.
Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Health Technology |
- Stock Market
- Insiders
- Benoit Bouche
